Nektar Therapeutics , a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its upsized underwritten ...
Expands potential opportunities for AKTX-101 and its novel RNA splicing modulator payload in additional tumors beyond current ...
Q1 2026 Earnings Call April 21, 2026 8:00 AM EDTCompany ParticipantsRachel VatnsdalRainer Blair - President, CEO ...
A new study finds the proteins responsible for controlling which genes are expressed in a genome do more than simply turn a ...
Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ ...
Dr. Mitch Rosner is the CEO of U.Va. Health and Executive Vice President of Health Affairs at the University. He can be ...
A study shows epigenetic proteins regulate genes through diverse dynamic patterns, not simple on-off control, with each ...
The US Food and Drug Administration (FDA) has issued warning letters to several drug manufacturers and compounders for ...
Complete and durable regression and anti-tumor immune memory following treatment with FHD-909 (LY4050784) in combination with an anti-PD-1 ...
The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...
Recycling waste into cash opens big doors for startups and small businesses, turning trash into jobs and growth ...
Leading by example, EZE Cloud Consulting, an official Services, Sales, and Innovation Partner of Workday, Inc., the enterprise AI platform for managing people, finance, and agents, has implemented the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results